ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,606Medicare Part D Prescriptions Filled, Including Refills

Rank: 252 out of 2035

$570K Total Retail Price of All Prescriptions

Rank: 225 out of 2035

231 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 231 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 7,673 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
METOPROLOL TARTRATE 274 210 1 8
LISINOPRIL 250 232 2 3
OMEPRAZOLE 246 213 3 5
SIMVASTATIN 229 211 4 1
AMLODIPINE BESYLATE 226 208 5 6
METFORMIN HCL 223 203 6 9
LEVOTHYROXINE SODIUM 214 204 7 4
FUROSEMIDE 212 204 8 7
HYDROCODONE-ACETAMINOPHEN 180 114 S3 9 2
ZOLPIDEM TARTRATE 156 153 10 21
ACETAMINOPHEN-CODEINE 127 114 S3 11 52
ATORVASTATIN CALCIUM 124 124 12 13
CARVEDILOL 123 123 13 22
CLOPIDOGREL 122 111 14 30
NEXIUM 119 107 15 51
POTASSIUM CHLORIDE 119 99 15 18
ATENOLOL 110 106 17 10
TAMSULOSIN HCL 110 98 17 25
LIDODERM 107 95 19 72
ISOSORBIDE MONONITRATE ER 100 100 20 32
CLONIDINE HCL 96 89 21 61
PRAVASTATIN SODIUM 91 88 22 17
ALLOPURINOL 85 73 23 34
DIOVAN 81 81 24 76
GLIMEPIRIDE 78 68 25 55
CRESTOR 78 66 25 41
SERTRALINE HCL 77 62 27 23
SPIRIVA 74 72 28 44
DONEPEZIL HCL 71 59 29 24
NIFEDIPINE ER 71 66 29 98
ENALAPRIL MALEATE 70 57 31 60
METOPROLOL SUCCINATE 69 69 32 16
IBUPROFEN 67 65 33 43
PLAVIX 65 57 34 49
NAMENDA 61 61 35 37
CYMBALTA 60 27 36 59
ADVAIR DISKUS 60 45 36 38
HYDROCHLOROTHIAZIDE 59 59 38 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 39 26
LOSARTAN POTASSIUM 58 56 39 15
PANTOPRAZOLE SODIUM 57 55 41 42
MECLIZINE HCL 54 54 42 147
MIRTAZAPINE 54 54 42 46
CELEBREX 53 41 44 104
VYTORIN 51 51 45 240
BENICAR 50 50 46 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.